A randomized, placebo-controlled study on the effect of cyclic intermittent etidronate therapy on the bone mineral density changes associated with six months of gonadotropin-releasing hormone agonist treatment
- 1 July 1996
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 175 (1) , 105-109
- https://doi.org/10.1016/s0002-9378(96)70258-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic painFertility and Sterility, 1993
- Effect of Gonadotropin-Releasing Hormone Agonists on Bone MetabolismSeminars in Reproductive Medicine, 1993
- Endometriosis and Infertility: Physiologic Mechanisms and Contemporary Therapeutic Considerations, Including GnRH AgonistsSeminars in Reproductive Medicine, 1993
- Treatment of Uterine Myomas with GnRH AgonistsSeminars in Reproductive Medicine, 1993
- Interval bone mineral density with long-term gonadotropin-releasing hormone agonist suppressionFertility and Sterility, 1989
- The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone MetabolismJournal of Clinical Endocrinology & Metabolism, 1988
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteriFertility and Sterility, 1988
- Increased Bone Turnover During Gonadotropin-Releasing Hormone Superagonist-Induced Ovulation Inhibition*Journal of Clinical Endocrinology & Metabolism, 1987
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984